🔴 Rezolute is trading 5% down today amid biotech-sector selloff

Rezolute is trading 5% down at $4.73 after a broad biotech-sector selloff; XBI fell 2.31% during regular trading.

• The decline appears sector-driven. Searches found no major Rezolute announcement or fresh clinical, regulatory, earnings, financing, or analyst catalyst on August 28, 2026.
• Investors are reducing higher-risk biotech exposure ahead of Federal Reserve Chair Kevin Warsh’s Jackson Hole remarks; major indexes were modestly positive.
• Trading activity and volume details were unavailable from reliable sources, so the assessment may warrant rechecking later.